Press Release
Infectious Disease Experts Available to Discuss Hepatitis B Prevention
NFID has spokespersons and resources to help increase awareness about the importance of adult vaccination and screening for hepatitis B
NFID Releases Progress Report on Respiratory Syncytial Virus (RSV) Prevention and Treatment
NFID has issued a new report on current efforts and progress in addressing respiratory syncytial virus (RSV) in the US
Rise in Measles Cases Raises Concerns for Public Health Experts
Concern about the spread of measles in several states has prompted public health experts to urge parents to make sure their children are up to date on measles-mumps-rubella (MMR) vaccination
US Health Officials Urge Vaccination To Help Protect Against a Potentially Severe Flu Season
Following a mild flu season in 2021-2022, an NFID survey shows only 49% of US adults plan to get a flu vaccine this season
NFID Announces 2022-2023 Board of Directors
NFID is pleased to announce the 2022-2023 NFID Board of Directors and updated slate of officers
NFID Announces Recipients of Prestigious 2022 Infectious Disease Awards
Public health heroes will be honored at a black-tie event
Experts To Discuss Impacts of COVID-19 on Vaccinology Research
Leading experts will examine the profound impacts of COVID-19 on the future of vaccinology at the Annual Conference on Vaccinology Research
NFID Urges Action to Reduce Burden of Respiratory Syncytial Virus (RSV)
New report includes strategies to improve surveillance, prevention, and treatment of RSV as an underappreciated public health threat
NFID Surveys Find Gaps in Communication about Flu Between Healthcare Professionals and Patients with Chronic Health Conditions
Disconnect between patients and HCPs on flu vaccine recommendations may put patients at risk Less than one third (31 percent) of HCPs say they recommend…
US Health Officials Urge Vaccination Amid Concerns About Influenza Resurgence During Ongoing Pandemic
NFID Survey Shows 44 Percent Of US Adults Are Unsure Or Do Not Plan To Get Vaccinated Against Flu, Including 1 In 4 Of Those…